{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:23Z","timestamp":1790610803404,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T00:00:00Z","timestamp":1685836800000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.semarthrit.2022.152036","type":"journal-article","created":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T11:03:25Z","timestamp":1653735805000},"page":"152036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Genetics are not likely to offer clinically useful predictions for elevated liver enzyme levels in patients using low dose methotrexate"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-1741","authenticated-orcid":false,"given":"Jing","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I.","family":"Chasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth W.","family":"Karlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.semarthrit.2022.152036_bib0001","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJM194806032382301","article-title":"Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid","volume":"238","author":"Farber","year":"1948","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.semarthrit.2022.152036_bib0002","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJM198503283121303","article-title":"Efficacy of low-dose methotrexate in rheumatoid arthritis","volume":"312","author":"Weinblatt","year":"1985","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152036_bib0003","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10067-014-2546-x","article-title":"Indispensable or intolerable? Methotrexate in patients with rheumatoid and psoriatic arthritis: a retrospective review of discontinuation rates from a large UK cohort","volume":"33","author":"Nikiphorou","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152036_bib0004","first-page":"1017","article-title":"Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature","volume":"27","author":"Visser","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152036_bib0005","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/pds.1209","article-title":"Hy's law,' the 'Rezulin Rule,' and other predictors of severe drug-induced hepatotoxicity: putting risk-benefit into perspective","volume":"15","author":"Lewis","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis & rheumatology (Hoboken, NJ."},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0007","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","article-title":"Drug-induced liver injury","volume":"89","author":"Leise","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152036_bib0008","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00393-015-1618-x","article-title":"Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis: a meta-analysis","volume":"75","author":"Lee","year":"2016","journal-title":"Z Rheumatol"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152036_bib0009","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s10067-014-2645-8","article-title":"Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis","volume":"33","author":"Song","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152036_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/FPC.0b013e32834ded2a","article-title":"Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis","volume":"22","author":"Spyridopoulou","year":"2012","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0011","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jhep.2017.03.010","article-title":"Minocycline hepatotoxicity: clinical characterization and identification of HLA-B *35:02 as a risk factor","volume":"67","author":"Urban","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0012","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152036_bib0013","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study","volume":"152","author":"Nicoletti","year":"2017","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.semarthrit.2022.152036_bib0014","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2217\/pgs-2021-0064","article-title":"Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate","volume":"22","author":"Sundbaum","year":"2021","journal-title":"Pharmacogenomics"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152036_bib0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.01.034","article-title":"A missense variant in PTPN22 is a risk factor for drug-induced liver injury","volume":"156","author":"Cirulli","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0016","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41467-020-20870-1","article-title":"Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology","volume":"12","author":"Chen","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152036_bib0017","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Joint, Bone, Spine"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152036_bib0018","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2217\/14622416.9.4.439","article-title":"An update on methotrexate pharmacogenetics in rheumatoid arthritis","volume":"9","author":"Ranganathan","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152036_bib0019","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semarthrit.2017.02.003","article-title":"Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: rationale and design of the cardiovascular inflammation reduction trial-adverse events (CIRT-AE) Study","volume":"47","author":"Sparks","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152036_bib0021","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M19-3369","article-title":"Adverse effects of low-dose methotrexate: a randomized trial","volume":"172","author":"Solomon","year":"2020","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152036_bib0022","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152036_bib0023","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152036_bib0024","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0025","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.1038\/s41598-021-85333-z","article-title":"Impact of pre- and post-variant filtration strategies on imputation","volume":"11","author":"Charon","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152036_bib0026","doi-asserted-by":"crossref","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","article-title":"Imputing amino acid polymorphisms in human leukocyte antigens","volume":"8","author":"Jia","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152036_bib0027","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3748\/wjg.v21.i8.2419","article-title":"Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"18","key":"10.1016\/j.semarthrit.2022.152036_bib0028","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/bioinformatics\/btq419","article-title":"LocusZoom: regional visualization of genome-wide association scan results","volume":"26","author":"Pruim","year":"2010","journal-title":"Bioinformatics"},{"issue":"15","key":"10.1016\/j.semarthrit.2022.152036_bib0029","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","article-title":"The variant call format and VCFtools","volume":"27","author":"Danecek","year":"2011","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152036_bib0030","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/art.1780370304","article-title":"Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American college of rheumatology","volume":"37","author":"Kremer","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152036_bib0031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152036_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003669","article-title":"Pyronaridine-artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: a single-arm, open-label, cohort event monitoring study","volume":"18","author":"Tona Lutete","year":"2021","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152036_bib0033","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/liv.14330","article-title":"The safety of stopping nucleos(t)ide analogue treatment in patients with HBeAg-negative chronic hepatitis B","volume":"40","author":"Wong","year":"2020","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152036_bib0034","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1586\/erm.10.36","article-title":"Current concepts in the genetic diagnostics of rheumatoid arthritis","volume":"10","author":"Nagy","year":"2010","journal-title":"Expert Rev Mol Diagn"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:10:39Z","timestamp":1758733839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":34,"alternative-id":["S0049017222000877"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152036","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics are not likely to offer clinically useful predictions for elevated liver enzyme levels in patients using low dose methotrexate","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152036"}}